References in periodicals archive ?
BTG, who services more than 3,000 customers worldwide, has an extensive global network with skilled application and service engineers who understand the customers' needs.
BTG creates value by investing in intellectual property and technology development, and in early stage ventures.
In September 2004, BTG filed suit in Federal Court in Delaware against Amazon.
BTG is also the manufacturer of DUROBLADE[R] high-performance blades for coating, creping, cleaning and flexo printing, DUROROD[TM] - a smooth rod for coating and size press applications, as well as the CBC (Creping Blade Control) blade holder.
BTG now seeks to exclusively license this technology to one OLED manufacturing company, thereby giving them a competitive position in growing markets for polymer OLED products.
We believe that safe and effective drug treatments are achievable for sleep apnea and we are delighted to have BTG as a strategic partner in this development program," added Dr.
Reisman began his partnership with BTG in 1998, to protect and commercialize his "transporter" technology.
BTG is investing in developing an innovative drug portfolio in diseases of ageing, which we will look to license to pharmaceutical partners to become the medicines of the future.
This deal shows the value that we create for our partners like ICR, and confirms that BTG is an important source of exciting new cancer drugs for the pharmaceutical industry.
BTG (LSE:BGC), a global technology commercialization company, and Corning Incorporated (NYSE:GLW), a diversified technology company, announced today that they have signed a representation agreement whereby BTG will seek licensees on behalf of Corning for a portfolio of Corning patents related to a widely-used glass molding process.
BTG (LSE: BGC), the global intellectual property and technology commercialization company, announced today that it has appointed Fulcrum Pharma Development Ltd.
DxS and BTG (LSE: BGC) announced today that they have signed an exclusive license with AstraZeneca to commercialize the company's proprietary Amplification Refractory Mutation System (ARMS(TM)) DNA diagnostic technology.